CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Top Player Positioning, 2017
3.4. Patent analysis, 2010-2018

3.4.1. Patent analysis, by year (2010-2018)
3.4.2. Patent analysis, by country

3.5. High-intensity focused ultrasound (HIFU): innovative products

3.5.1. Focal-One
3.5.2. Ulthera system
3.5.3. Exablate Neuro

3.6. Market dynamics

3.6.1. Drivers

3.6.1.1. Favorable regulatory scenario
3.6.1.2. Rise in awareness for early disease diagnosis
3.6.1.3. Rapid increase in elderly population

3.6.2. Restraints

3.6.2.1. Limitations of HIFU therapy
3.6.2.2. Dearth of skilled professionals

3.6.3. Opportunity

3.6.3.1. Untapped potential of the emerging economies

CHAPTER 4: HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) THERAPY MARKET, BY APPLICATION

4.1. Overview

4.1.1. Market size and forecast

4.2. Prostate cancer

4.2.1. Market size and forecast
4.2.2. Market analysis, by country

4.3. Uterine fibroids

4.3.1. Market size and forecast
4.3.2. Market analysis, by country

4.4. Neurological disorders

4.4.1. Market size and forecast
4.4.2. Market analysis, by country

4.5. Aesthetics

4.5.1. Market size and forecast
4.5.2. Market analysis, by country

4.6. Others

4.6.1. Market size and forecast
4.6.2. Market analysis, by country

CHAPTER 5: HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) MARKET, BY REGION

5.1. Overview

5.1.1. Market size and forecast

5.2. North America

5.2.1. Key market trends, growth factors, and opportunities
5.2.2. North America HIFU market size and forecast, by country

5.2.2.1. U.S. market size and forecast
5.2.2.2. Canada market size and forecast
5.2.2.3. Mexico market size and forecast

5.2.3. North America HIFU market size and forecast, by Application
5.2.4. North America HIFU market size and forecast, by Industry

5.3. Europe

5.3.1. Key market trends, growth factors and opportunities
5.3.2. Europe HIFU market size and forecast, by country

5.3.2.1. Germany market size and forecast
5.3.2.2. France market size and forecast
5.3.2.3. UK market size and forecast
5.3.2.4. Italy market size and forecast
5.3.2.5. Spain market size and forecast
5.3.2.6. Rest of Europe market size and forecast

5.3.3. Europe HIFU market size and forecast, by Application

5.4. Asia-Pacific

5.4.1. Key market trends, growth factors and opportunities
5.4.2. Asia-Pacific HIFU market size and forecast, by country

5.4.2.1. Japan market size and forecast
5.4.2.2. China market size and forecast
5.4.2.3. India market size and forecast
5.4.2.4. Australia market size and forecast
5.4.2.5. South Korea market size and forecast
5.4.2.6. Rest of Asia-Pacific market size and forecast

5.4.3. Asia-Pacific HIFU market size and forecast, by Application

5.5. LAMEA

5.5.1. Key market trends, growth factors and opportunities
5.5.2. LAMEA HIFU market size and forecast, by country

5.5.2.1. Brazil market size and forecast
5.5.2.2. Saudi Arabia market size and forecast
5.5.2.3. South Africa market size and forecast
5.5.2.4. Rest of LAMEA market size and forecast

5.5.3. LAMEA HIFU market size and forecast, by Application

CHAPTER 6:

6.1. Chongqing Haifu Medical Technology Co., Ltd.

6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Product portfolio
6.1.4. Key strategic moves and developments

6.2. EDAP TMS S.A.

6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Business performance
6.2.6. Key strategic moves and developments

6.3. ILJIN Holdings Co., Ltd. (ALPINION MEDICAL SYSTEMS Co., Ltd.)

6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Product portfolio

6.4. Merz Pharmaceuticals GmbH (Ulthera, Inc.)

6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Product portfolio

6.5. Theraclion SA

6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Business performance
6.5.4. Product portfolio
6.5.5. Key strategic moves and developments

6.6. Image Guided Therapy S.A.

6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Product portfolio

6.7. INSIGHTEC Ltd.

6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Product portfolio

6.8. Profound Medical Corp.

6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Product portfolio
6.8.4. Key strategic moves and developments

6.9. SonaCare Medical, LLC.

6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Product portfolio

6.10. Shanghai A&S Technology Development Co., Ltd.

6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Product portfolio